ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30
Advanced Biomed Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$4.16+0.18 (+4.52%)
Close on Oct 19, 2026
- Market cap
- $6.51M
- P/E (TTM)
- 0.8
- Dividend yield
- –